Logo image
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption
Journal article   Peer reviewed

Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption

John M SANDERS, YONGCHENG SONG, Gary A MEINTS, Aurora Ortiz GOMEZ, Dolores GONZALEZ-PACANOWSKA, Amy M RAKER, HONG WANG, Ermond R VAN BEEK, Socrates E PAPAPOULOS, Craig T MORITA, …
Journal of medicinal chemistry, Vol.48(8), pp.2957-2963
2005
DOI: 10.1021/jm040209d
PMID: 15828834
url
https://doi.org/10.7270/q2z89d7kView
Open Access

Abstract

We report the design, synthesis and testing of a series of novel bisphosphonates, pyridinium-1-yl-hydroxy-bisphosphonates, based on the results of comparative molecular similarity indices analysis and pharmacophore modeling studies of farnesyl diphosphate synthase (FPPS) inhibition, human Vgamma2Vdelta2 T cell activation and bone resorption inhibition. The most potent molecules have high activity against an expressed FPPS from Leishmania major, in Dictyostelium discoideum growth inhibition, in gammadelta T cell activation and in an in vitro bone resorption assay. As such, they represent useful new leads for the discovery of new bone resorption, antiinfective and anticancer drugs.
Biological and medical sciences Medical sciences Immunomodulators Pharmacology. Drug treatments Bones, joints and connective tissue. Antiinflammatory agents

Details

Metrics

Logo image